FNB
AZN icon

Farmers National Bank’s AstraZeneca AZN Stock Holding History

Farmers National Bank’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,172
Closed -$215K – 186
2025
Q4 		$215K Buy
+1,172
New +$206K 0.05% 177

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Farmers National Bank's AZN Position: Q1 2026 in Review

Farmers National Bank sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 1,172 shares — an estimated $215K sold.

Farmers National Bank first reported a position in AZN in Q4 2025 and held it in 1 quarter. The position peaked at $215K in Q4 2025. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Farmers National Bank reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Farmers National Bank sold 1,172 AstraZeneca shares in Q1 2026, an estimated $215K.
  • Farmers National Bank first reported a position in AstraZeneca in Q4 2025 and held it in 1 quarter.
  • Farmers National Bank's AstraZeneca position peaked at $215K in Q4 2025.
  • 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Farmers National Bank's 13F filing for Q1 2026, filed 8 Jun 2026.